Literature DB >> 3040357

Effect of misoprostol on histamine-stimulated acid secretion and cyclic AMP formation in isolated canine parietal cells.

B S Tsai, L K Kessler, G M Butchko, R F Bauer.   

Abstract

Isolated canine parietal cells were used to study the ability of misoprostol to inhibit acid secretion in the presence of a number of acid secretagogues. Misoprostol inhibited histamine-stimulated acid secretion in a dose-dependent and noncompetitive manner. A concentration of 2-3 X 10(-9) M misoprostol inhibited maximal histamine-stimulated acid secretion by one half. Misoprostol had little to no effect on acid secretion stimulated by carbachol and dibutyryl cAMP, had no effect on the acid secretion directly stimulated by pentagastrin, and only modestly inhibited acid secretion stimulated by forskolin. Misoprostol noncompetitively inhibited cAMP formation in response to histamine, with an IC50 value similar to that for the inhibition of histamine-stimulated acid secretion. These results indicate that: (1) misoprostol specifically inhibits histamine-stimulated acid secretion in parietal cells, and (2) the antisecretory action of misoprostol is closely related to the reduction of histamine-stimulated cAMP formation with the site of major action most likely in the coupling process between histamine H2 receptor sites and histamine-sensitive adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040357     DOI: 10.1007/BF01297192

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  Cytoprotection by prostaglandins.

Authors:  A Robert
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

2.  The localization of a histamine H2-receptor adenylate cyclase system in canine parietal cells and its inhibition by prostaglandins.

Authors:  J S Major; P Scholes
Journal:  Agents Actions       Date:  1978-06

3.  Metiamide, an H2-receptor blocker, as inhibitor of basal and meal-stimulated gastric acid secretion in patients with duodenal ulcer.

Authors:  M Mainardi; V Maxwell; R A Sturdevant; J I Isenberg
Journal:  N Engl J Med       Date:  1974-08-22       Impact factor: 91.245

4.  Comparative gastric antisecretory and antiulcer effects of prostaglandin E1 and its methyl ester in animals.

Authors:  E Z Dajani; D R Driskill; R G Bianchi; P W Collins
Journal:  Prostaglandins       Date:  1975-08

5.  The actions of secretagogues on oxygen uptake by isolated mammalian parietal cells.

Authors:  A H Soll
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

6.  Synthesis and gastric antisecretory properties of 4,5-unsaturated derivatives of 15-deoxy-16-hydroxy-16-methylprostaglandin E1.

Authors:  P W Collins; E Z Dajani; R Pappo; A F Gasiecki; R G Bianchi; E M Woods
Journal:  J Med Chem       Date:  1983-06       Impact factor: 7.446

7.  Inhibition of basal and stimulated gastric H+ and pepsin secretion in duodenal ulcer patients by metiamide, an H-2 histamine antagonist.

Authors:  S C Bajaj; B I Hirschowitz
Journal:  Am J Dig Dis       Date:  1976-07

8.  Specific inhibition by prostaglandins E2 and I2 of histamine-stimulated [14C]aminopyrine accumulation and cyclic adenosine monophosphate generation by isolated canine parietal cells.

Authors:  A H Soll
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

Review 9.  Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

Authors:  K B Seamon; J W Daly
Journal:  J Cyclic Nucleotide Res       Date:  1981

10.  Chemistry and synthetic development of misoprostol.

Authors:  P W Collins; R Pappo; E Z Dajani
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

View more
  2 in total

1.  Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid.

Authors:  B S Tsai; L K Kessler; J Stolzenbach; G Schoenhard; R F Bauer
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

2.  Effects of the H2-antagonists famotidine and nizatidine and the cytoprotectant misoprostol on human colonic and rat peritoneal mast cells.

Authors:  P M Shah; P B Boulos; R Springall; R Vashisht; F L Pearce
Journal:  Agents Actions       Date:  1994-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.